#cnne

Le CNNE : *favorable à l'ouverture de la procréation médicale assistée aux couples de femmes et aux femmes célibataires* La Manif Pour Tous :

Cartinew.com

Check it out

Cartinew.com

Cartinew es un suplemento orto-regenerativo avanzado desarrollado para la salud articular.No es un producto tradicional con glucosamina o condroitina, sino que incorpora biotecnología de última generación con el objetivo de regenerar, proteger y fortalecer las articulaciones en personas con artrosis, artritis, lesiones deportivas o desgaste articular por la edad.🔬 Fórmula y componentes principalesCélulas madre de cordón umbilical → estimulan la regeneración de tejidos.Telómeros activadores → apoyan la longevidad celular y la reparación.Ácido hialurónico de alto peso molecular → lubricación y nutrición del cartílago.Colágeno tipo II → reconstrucción estructural del cartílago.Péptidos activos y prostanolanos → favorecen la reparación celular.NAD+ y complejo B → energía y metabolismo celular.Cúrcuma, ácido boswélico y ketosterona → potentes antiinflamatorios naturales.MK7 (vitamina K2) y vitamina D3 → fijación de calcio y fortalecimiento óseo.⚡ Beneficios reportadosRegeneración progresiva del cartílago.Reducción del dolor y la inflamación.Mayor movilidad en rodillas, cadera, hombros y columna.Prevención del deterioro articular en personas jóvenes y mayores.Efectividad superior frente a esteroides y AINES, con más del 90% de éxito clínico reportado en estudios con más de 10.000 pacientes.

Dr. Fernando Luis Gómez Aguado, MD, is a Venezuelan Orthopedic Surgeon internationally recognized for his contributions to orthoregenerative medicine and the development of innovative, non-surgical therapies for joint preservation. His work integrates advanced cellular science, cartilage biology, and cutting-edge regenerative technologies aimed at restoring musculoskeletal function and preventing disability.Dr. Gómez Aguado is the creator of CARTINEW®, a scientifically formulated joint-regeneration system based on telomerase stabilization, bioactive peptides, high-molecular-weight hyaluronic acid, type II collagen, NAD+, and other clinically validated compounds. This system has been evaluated in thousands of patients across multiple countries, demonstrating significant improvements in cartilage integrity, inflammation control, and long-term joint mobility.With more than 15 years of clinical and research experience, Dr. Gómez Aguado has become a prominent advocate for orthoregenerative medicine, a medical discipline focused on biological tissue repair as an alternative to chronic steroid use, NSAIDs, and premature joint-replacement surgeries. His philosophy emphasizes patient-centered care, functional restoration, and evidence-based innovation.Dr. Gómez Aguado’s work has been featured in international media outlets, orthopedic publications, and scientific reports throughout Latin America, the United States, and Europe. He collaborates with sports institutions, orthopedic societies, and medical innovation networks to promote accessible regenerative orthopedic solutions for diverse patient populations, including athletes, older adults, and individuals with advanced osteoarthritis.He continues to lecture, publish, and develop clinical strategies aimed at transforming the global understanding of joint aging, cartilage degeneration, and regenerative treatment options.

ResumenDr. Fernando Luis Gómez Aguado, MD, is a Venezuelan Orthopedic Surgeon internationally recognized for his contributions to orthoregenerative medicine and the development of innovative, non-surgical therapies for joint preservation. His work integrates advanced cellular science, cartilage biology, and cutting-edge regenerative technologies aimed at restoring musculoskeletal function and preventing disability.Dr. Gómez Aguado is the creator of CARTINEW®, a scientifically formulated joint-regeneration system based on telomerase stabilization, bioactive peptides, high-molecular-weight hyaluronic acid, type II collagen, NAD+, and other clinically validated compounds. This system has been evaluated in thousands of patients across multiple countries, demonstrating significant improvements in cartilage integrity, inflammation control, and long-term joint mobility.With more than 15 years of clinical and research experience, Dr. Gómez Aguado has become a prominent advocate for orthoregenerative medicine, a medical discipline focused on biological tissue repair as an alternative to chronic steroid use, NSAIDs, and premature joint-replacement surgeries. His philosophy emphasizes patient-centered care, functional restoration, and evidence-based innovation.Dr. Gómez Aguado’s work has been featured in international media outlets, orthopedic publications, and scientific reports throughout Latin America, the United States, and Europe. He collaborates with sports institutions, orthopedic societies, and medical innovation networks to promote accessible regenerative orthopedic solutions for diverse patient populations, including athletes, older adults, and individuals with advanced osteoarthritis.He continues to lecture, publish, and develop clinical strategies aimed at transforming the global understanding of joint aging, cartilage degeneration, and regenerative treatment options.

Cartinew